Skip to main content
QUCY
NASDAQ Life Sciences

Quantum Cyber Regains Nasdaq Compliance, Resolving Delisting Threat

Arie Shkolnikov · Analysis by Wiseek AI
More coverage: Diagnostics & Research Stocks · Healthcare
Sentiment info
Positive
Importance info
8
Price
$2.94
Mkt Cap
$43.69M
52W Low
$0.3
52W High
$4.93
52W Position info
880% above low
Off High info
40% below high
Rel. Volume info
0.2× avg
Market data snapshot near publication time

QUCY has more than doubled off its 52-week low of $0.3 on light trading volume (0.2× avg).

Summary

Quantum Cyber N.V. has regained compliance with Nasdaq's minimum bid price requirement, removing the immediate threat of delisting.


Key Events · Corporate Governance and Compliance · QUCY

  • Nasdaq Compliance Regained

    The company's ordinary shares maintained a closing bid price of $1.00 or greater for 10 consecutive business days, from May 13 to May 27, 2026.

  • Delisting Threat Removed

    This action resolves the previously disclosed non-compliance with Nasdaq Listing Rule 5550(a)(2), closing the matter with Nasdaq.

  • Follows Prior Non-Compliance Notice

    This positive development follows the Nasdaq notice of non-compliance received on March 20, 2026.


Analysis · QUCY · Life Sciences

This 8-K reports that Quantum Cyber's stock price has traded above $1.00 for 10 consecutive business days, resolving the Nasdaq minimum bid price deficiency first reported on March 25, 2026. This removes an immediate delisting threat and provides some stability amidst the company's ongoing business pivot and significant dilution.

How filings like this one have moved

In the 30 days to Sep 15, 2026, 35.6% of the 1100 measured filings Wiseek scored 8 moved their stock by 5% or more by the next session's close. The median move was -0.43%. These are measured outcomes after filings of this importance, not a forecast for this one.

Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset

At the time of this filing, QUCY was trading at $2.94 on NASDAQ in the Life Sciences sector, with a market capitalization of approximately $43.7M. The 52-week trading range was $0.30 to $4.93. This filing was assessed with positive market sentiment and an importance score of 8 out of 10.

View Main SEC Filing

Price Chart

Share this article

Copied!

QUCY - Latest Insights

QUCY
Aug 31, 2026, 7:30 AM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.49
Real-time Price: $1.31 info
Change: -$0.1795 (-12%) info
Market Cap: $110.171M info
QUCY
Aug 20, 2026, 4:01 PM EDT
Source: GlobeNewswire
Importance Score:
7
Price at Filing: $1.36
Real-time Price: $1.31 info
Change: -$0.0495 (-4%) info
Market Cap: $110.171M info
QUCY
Aug 14, 2026, 8:00 AM EDT
Filing Type: 10-Q
Importance Score:
9
Price at Filing: $1.47
Real-time Price: $1.31 info
Change: -$0.1595 (-11%) info
Market Cap: $110.171M info
QUCY
Aug 10, 2026, 9:43 AM EDT
Source: Reuters
Importance Score:
7
Price at Filing: $1.38
Real-time Price: $1.31 info
Change: -$0.0645 (-5%) info
Market Cap: $110.171M info
QUCY
Aug 07, 2026, 6:51 PM EDT
Filing Type: 4
Importance Score:
9
Price at Filing: $1.47
Real-time Price: $1.31 info
Change: -$0.1549 (-11%) info
Market Cap: $110.171M info